An evaluation of a modified nystatin vaginal tablet in a multi-centre study.
D000328:Adult; D002176:Candida albicans / Q000302:isolation & purification*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003258:Consumer Behavior; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008598:Menstruation; D009761:Nystatin / Q000008:administration & dosage* / Q000627:therapeutic use; D010570:Pessaries / Q000009:adverse effects; D014677:Pharmaceutical Vehicles; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D013607:Tablets; D013997:Time Factors; D014626:Vaginal Smears
D014677:Pharmaceutical Vehicles; D013607:Tablets; D009761:Nystatin